当前位置:首页 - 行情中心 - 以岭药业(002603) - 财务分析 - 资产负债表

以岭药业

(002603)

  

流通市值:277.59亿  总市值:336.98亿
流通股本:13.76亿   总股本:16.71亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金1,072,618,858.341,755,175,318.371,035,610,064.491,904,276,443.11
应收票据及应收账款2,488,005,278.652,250,963,716.061,938,660,386.861,726,806,702.36
应收账款2,488,005,278.652,250,963,716.061,938,660,386.861,726,806,702.36
应收款项融资165,086,019.1188,067,457.74769,645,711.25450,858,938.67
预付款项233,848,392.17212,623,149.35293,608,735.47516,332,322.53
其他应收款合计6,540,915.956,336,535.976,281,901.995,569,410.16
存货2,426,612,839.92,512,358,043.532,822,132,114.82,021,821,524.2
其他流动资产196,110,357.67126,877,906.84198,335,973.39110,138,701.08
流动资产平衡项目0000
流动资产合计6,824,834,078.457,457,074,433.418,459,996,568.817,254,187,281.44
非流动资产:
长期股权投资2,487,006.52,487,165.522,497,013.352,497,013.35
其他非流动金融资产1,963,145,276.072,048,627,803.851,842,091,4081,346,406,039.94
投资性房地产26,817,939.622,538,959.423,241,114.4423,347,715.51
固定资产5,342,326,175.15,420,008,231.244,823,914,115.494,625,112,737.47
在建工程1,630,301,772.911,568,262,414.91,508,753,516.831,574,299,595.09
生产性生物资产8,446,766.937,361,0277,691,470.297,523,014.68
使用权资产18,234,564.5519,972,449.6220,630,660.322,375,646.53
无形资产751,423,662.1758,544,008.11717,661,074.74724,011,772.81
开发支出157,368,333.25121,395,866.37110,943,208.54103,943,286.61
商誉114,237,413.4114,237,413.4--
长期待摊费用2,607,154.572,811,624.243,019,632.143,221,396.92
递延所得税资产118,066,156.15166,060,620.52256,616,649.99281,966,822.92
其他非流动资产474,707,497.4444,216,524.16469,644,373.46369,307,158.89
非流动资产平衡项目0000
非流动资产合计10,610,169,718.5310,696,524,108.339,786,704,237.579,084,012,200.72
资产平衡项目0000
资产总计17,435,003,796.9818,153,598,541.7418,246,700,806.3816,338,199,482.16
流动负债:
短期借款900,503,2501,000,572,000700,415,750500,345,277.77
应付票据及应付账款2,306,401,657.742,860,274,020.242,788,444,066.252,060,775,874.38
其中:应付票据421,028,120.92564,122,631.83629,950,971.25580,917,684
应付账款1,885,373,536.822,296,151,388.412,158,493,0951,479,858,190.38
合同负债212,687,944.91421,030,427.591,194,424,310.681,105,752,030.71
应付职工薪酬235,758,117.53265,900,331.67307,439,569.81379,771,579.41
应交税费180,032,292.66153,286,315.72291,297,161.05474,001,627.98
其他应付款合计534,121,810.31920,595,442.4287,687,531.79120,290,326.31
应付股利451,800,045830,352,688--
一年内到期的非流动负债4,408,158.885,301,669.84155,069,019.08155,980,819.77
其他流动负债18,048,611.7312,419,415.2137,664,397.4753,214,766.87
流动负债平衡项目0000
流动负债合计4,391,961,843.765,639,379,622.695,562,441,806.134,850,132,303.2
非流动负债:
长期借款700,400,527.78300,164,166.67200,135,000200,150,000
租赁负债12,662,215.3513,273,564.1314,038,61814,973,442.61
递延收益356,219,207.67378,780,464.24330,854,884.01335,022,508.03
递延所得税负债125,715,103.58124,742,487.347,177,724.037,649,406.64
非流动负债平衡项目0000
非流动负债合计1,194,997,054.38816,960,682.38552,206,226.04557,795,357.28
负债平衡项目0000
负债合计5,586,958,898.146,456,340,305.076,114,648,032.175,407,927,660.48
所有者权益(或股东权益):
实收资本(或股本)1,670,705,3761,670,705,3761,670,705,3761,670,705,376
资本公积2,342,780,896.142,342,780,896.142,342,780,896.142,342,780,896.14
其他综合收益-6,323,753.94-6,224,032.7-6,873,652.65-7,217,790.97
盈余公积936,770,495.27936,770,495.27936,770,495.27936,770,495.27
未分配利润6,912,510,113.26,759,846,718.477,191,692,773.625,989,178,389.49
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计11,856,443,126.6711,703,879,453.1812,135,075,888.3810,932,217,365.93
少数股东权益-8,398,227.83-6,621,216.51-3,023,114.17-1,945,544.25
股东权益平衡项目0000
股东权益合计11,848,044,898.8411,697,258,236.6712,132,052,774.2110,930,271,821.68
负债和股东权益合计17,435,003,796.9818,153,598,541.7418,246,700,806.3816,338,199,482.16
公告日期2023-10-282023-08-292023-04-262023-04-26
审计意见(境内)标准无保留意见
TOP↑